| |
Dinner Lecture
P R E S E N T I N G
T. Douglas Bradley, M.D.
Director,
Cardiopulmonary Sleep Disorders and Research Centre
Toronto General Hospital, University Health Network
Toronto, Canada
Seminary Contents
- Overview of obstructive (OSA) and central sleep
apnea (CSA) in patients with congestive heart
failure.
- Summary of the adverse hemodynamic and
neurohumoral effects of OSA and CSA in the setting
of CHF.
- Review of data supporting sleep apnea as an
independent risk factor of mortality in CHF.
- Discuss evidence that CPAP is a non-invasive
left ventricular assist device (LVAD).
- Acute effects of continuous positive airway
pressure (CPAP) on preload, after load and stroke
volume.
- Description of chronic hemodynamics and
neurohumoral effects of nasal CPAP in CHF patients
with OSA and CSA.
- Description of results of a randomized trial
involving CHF patients with CSA in which heart
transplant free survival was reduced in patients
compliant with CPAP.
- Brief summary of the design and progress of the
multi-center Canadian Positive Airway Pressure Trial
for Heart Failure (the NCANPAP) trial), and
ventricular remodeling as a secondary endpoint.
Location and Reservations
| Where: |
|
Al Dente Ristorante
1655 Stelton Road
Piscataway, NJ 08854
Click
here to get directions from your
location.
|
 |
| When: |
|
Thursday, March 6th
6:30 PM Cocktails
7:00 PM Dinner Lecture
|
Rescheduled due to adverse weather conditions.
Please
Contact MSO for information on alternative
date ! |
|
Reserve Your Seat: |
|
Call Kevin Sharkey at (201) 670-9999
or Email:
Kevin@MSObiz.com
|
Sponsorship Information
This program is sponsored by Scios and Cardiology
Sleep Solutions
|
HOME
BUY NOW
CONTACT US
